Sight Sciences Inc
$ 8.56
3.13%
03 Dec - close price
- Market Cap 452,582,000 USD
- Current Price $ 8.56
- High / Low $ 8.58 / 8.09
- Stock P/E N/A
- Book Value 1.23
- EPS -0.90
- Next Earning Report 2026-03-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.22 %
- ROE -0.58 %
- 52 Week High 8.80
- 52 Week Low 2.03
About
None
Analyst Target Price
$6.42
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-04-30 | 2025-03-05 | 2024-11-07 | 2024-08-01 | 2024-05-02 | 2024-03-07 | 2023-11-07 | 2023-08-03 | 2023-05-04 | 2023-03-13 |
| Reported EPS | -0.16 | -0.23 | -0.28 | -0.23 | -0.22 | -0.25 | -0.33 | -0.22 | -0.27 | -0.3 | -0.35 | -0.35 |
| Estimated EPS | -0.26 | -0.26 | -0.28 | -0.176 | -0.21 | -0.3 | -0.28 | -0.32 | -0.32 | -0.34 | -0.39 | -0.42 |
| Surprise | 0.1 | 0.03 | 0 | -0.054 | -0.01 | 0.05 | -0.05 | 0.1 | 0.05 | 0.04 | 0.04 | 0.07 |
| Surprise Percentage | 38.4615% | 11.5385% | 0% | -30.6818% | -4.7619% | 16.6667% | -17.8571% | 31.25% | 15.625% | 11.7647% | 10.2564% | 16.6667% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-05 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.2188 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SGHT
2025-10-18 13:16:27
Sight Sciences, Inc. (NASDAQ:SGHT) saw its share price surge 37% over the last month, despite a 21% decline over the past year. The company's price-to-sales ratio of 3.2x is similar to the Medical Equipment industry median of 2.9x. Analysts forecast an 11% per annum revenue climb for Sight Sciences over the next three years, slightly outpacing the industry's 9.2% growth.
2025-10-18 13:09:55
Sight Sciences, Inc. (NASDAQ:SGHT) shares have risen 37% over the last month, despite a 21% fall over the past year. Its current price-to-sales (P/S) ratio of 3.2x is similar to the Medical Equipment industry median of 2.9x, suggesting that investors expect moderate future growth in line with the industry, despite recent revenue declines. Analysts forecast an 11% per annum revenue growth over the next three years, aligning with the industry's projected 9.2% annual expansion.
2025-10-18 00:59:27
The article reports an application error, indicating that the content could not be loaded. It appears there was an issue displaying information about Medicare establishing pricing for Sight Sciences' TearCare System.
2025-10-17 23:51:43
The article reports that Medicare has established pricing for Sight Sciences' TearCare System. However, due to an application error, the full details of this development are not accessible within the provided content.
2025-10-17 15:52:45
The article indicates that there was an application error preventing the display of the news content. Therefore, no meaningful summary can be provided based on the given input, as the actual news story about Medicare establishing pricing for Sight Sciences' TearCare System is unavailable.
2025-10-17 11:57:42
This article from Investing.com is currently inaccessible due to a loading error. The title suggests it reports on Medicare establishing pricing for Sight Sciences' TearCare System, which would be significant news for the medical device company.
